Urszula N. Wasko

Revolution Medicines (United States)

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Revolution Medicines (United States)

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years

Columbia University Irving Medical Center

Research Subjects

Research Interests

Urszula N. Wasko has a total of 47 co-authors. Here are the top co-authors by number of shared publications:

Alexander Muir
Ben May Department for Cancer Research, University of Chicago
64 shared publications
Alice Ma
Department of Medicine, Division of Digestive and Liver Diseases, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York
64 shared publications
Alvaro Curiel-Garcia
Division of Digestive and Liver Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, USA
64 shared publications
Amanda R. Decker-Farrell
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA
64 shared publications
Andrea Califano
Department of Systems Biology, Columbia University, New York, USA
64 shared publications
Carmine F. Palermo
Columbia University Medical Center 1 Division of Digestive and Liver Diseases and Herbert Irving Comprehensive Cancer Center New York, New York
64 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
DNA primers used for PCR or Sanger seq.
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S5 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
DNA primers used for PCR or Sanger seq.
Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Quantitative PCR (qPCR) primers used on gDNA.
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S7 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Quantitative PCR (qPCR) primers used on gDNA.
Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Patient-derived xenografts (PDXs).
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S4 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Patient-derived xenografts (PDXs).
Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S6 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
CRISPR guideRNAs and associated primers.
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S6 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
CRISPR guideRNAs and associated primers.
Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Myr-dPH-AKT1:ER, Pten CRISPR, RAC1-P29S-eGFP.
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S9 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Myr-dPH-AKT1:ER, Pten CRISPR, RAC1-P29S-eGFP.
Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Schematic of GEMM alleles and Cre initiation schedules, IHC, and immunoblotting on GEMM tumors.
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S4 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Schematic of GEMM alleles and Cre initiation schedules, IHC, and immunoblotting on GEMM tumors.
Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Cell confluency or cytotoxicity assays, immunoblot analysis of O.10 and Mel-9.
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S1 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Cell confluency or cytotoxicity assays, immunoblot analysis of O.10 and Mel-9.
Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S10 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Supplementary Table S10 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S10 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Supplementary Table S10 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S11 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Supplementary Table S11 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S11 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Supplementary Table S11 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
Open Access
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Additional CYPA M136R, MEK1 P124L K57N Q56P.
Website
Google Scholar
- 14 August 2026
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S10 from Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma
by Mona Foth, Wontak Kim, Kayla O’TOole, Brandon Murphy, Montserrat Justo-Garrido, Sanjana Boggaram, Phaedra Ghazi, Euan Brennan, M. Isaac Wright, Tate Shepherd, et al.
Additional CYPA M136R, MEK1 P124L K57N Q56P.

Show all